Image (324e0a1f 31ad 4dd5 9693 70f5150f3b23 01)
Sucralfate Suspension
Product Images NDC 64380-149
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Sucralfate (NDC 64380-149). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
420ml-container-label (324e0a1f 31ad 4dd5 9693 70f5150f3b23 02)
This text provides information about a sucralfate oral suspension medication manufactured by Strides Pharma in India. The recommended adult dosage is 1g (2 teaspoons) four times a day on an empty stomach. It emphasizes the importance of shaking well before using and avoiding freezing. The medication should be stored at controlled room temperature and kept out of reach of children. The text also includes the NDC number, manufacturing address, and a reminder to consult the package insert for full prescribing information.*
Unit-dose-cup-label (324e0a1f 31ad 4dd5 9693 70f5150f3b23 03)
This text contains information about a sucralfate oral suspension medication with a National Drug Code (NDC) of 64380-149-02. The medication is to be shaken well before use and is intended for institutional use only. The product is manufactured by Strides Pharma Inc. in East Brunswick, NJ. The package includes a GTIN number of 0364380149026. Additionally, it mentions a "0| NO VARNISH ZONE" and indicates that it delivers 10 mL.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
